Navigation Links
VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ
Date:10/13/2009

ity date (or earlier if certain repayment acceleration provisions are triggered);
  • our ability to control our operating expenses;
  • our ability to comply with covenants included in the loan from Bay City Capital;
  • our ability to maintain the listing of our common stock on NASDAQ;
  • our ability to timely recruit and enroll patients in any future clinical trials;
  • our failure to obtain sufficient data from enrolled patients that can be used to evaluate VIA-2291, thereby impairing the validity or statistical significance of our clinical trials;
  • our ability to successfully complete our clinical trials of VIA-2291 on expected timetables and the outcomes of such clinical trials;
  • complexities in designing and implementing cardiometabolic clinical trials using surrogate endpoints in Phase 1 and Phase 2 clinical trials which may differ from the ultimate endpoints required for registration of a candidate drug;
  • the results of our clinical trials, including without limitation, with respect to the safety and efficacy of VIA-2291;
  • if the results of the ACS and CEA studies, upon further review and analysis, are revised, interpreted differently by regulatory authorities or negated by later stage clinical trials;
  • our ability to obtain necessary FDA approvals, including to initiate future clinical trials of VIA-2291;
  • our ability to successfully commercialize VIA-2291;
  • our ability to identify potential clinical candidates from the family of DGAT1 compounds licensed and move them into preclinical development;
  • our ability to obtain and protect our intellectual property related to our product candidates;
  • our potential for future growth and the development of our product pipeline, including the THR beta agonist candidate and the other compounds licensed from Roche;
  • our ability to obtain strategic opportunities to partner and collaborate with large biotechnology or pharmaceutic
    '/>"/>

    • SOURCE VIA Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4

    Related medicine technology :

    1. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
    2. Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
    3. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
    4. Onyx Pharmaceuticals to Acquire Proteolix, Inc.
    5. Onyx Pharmaceuticals Announces Investor Teleconference and Webcast
    6. ADVENTRX Pharmaceuticals Announces Closing of Financing
    7. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
    8. Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009
    9. Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
    10. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
    11. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/20/2009)..., , CARY, N.C., Nov. 20 /PRNewswire-FirstC...TX ), a specialty pharmaceutical company focused o...icant products primarily for the respiratory and r...d a Warning Letter from the Food and Drug Administ...ble tablets (Phenylephrine HCl 10 mg, Pyrilamine M...
    (Date:11/20/2009)..., , GLENWOOD, Ill., Nov. 20 /PRNewswire-Fir...se financial results for the fiscal fourth quarter...mber 1, 2009. ,, The company will host a confer...09, at 2:00 p.m. Eastern Time. Investors may acces...e United States and Canada), or 480-629-9835 (inte...
    (Date:11/20/2009)..., , HARRISBURG, Pa., Nov. 20 /PRNewswire-...n providing free H1N1 flu shots to members of prio...he vaccine. ,, A total of 18 clinics are being ...s are from 2 p.m. to 8 p.m. Hours on Saturday, Nov... the clinics will operate from 2 p.m. to 8 p.m. ,...
    Breaking Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 1HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 2HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 3HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 4Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 1Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 2Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 3Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 4Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 5Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 6MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage 47449 1MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage 47449 2MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage 47449 3MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage 47449 4MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage 47449 5
    ...be Assured of No Banned Substances, BASKING RIDGE...wholly-owned subsidiary of Millennium Biotechnolog...ced today that Surgex(TM), (http://www.surgexsport...ned,Substance Control Group,s (BSCG) certification...n the US that uses a World Anti Doping Agency,accr...
    ...uate Anti-Tumor Activity of Bavituximab in ...N, Calif., Jan. 29 Peregrine,Pharmaceuticals, Inc...ical,company developing targeted therapies for the...on (HCV), today announced that patient screening,h...the safety and efficacy,of bavituximab in combinat...
    Other Medicine Technology:Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance 2Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance 3Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance 4Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 2Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 3Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 4
    (Date:11/21/2009)... Eric J. Hall, president and chief executive ...AFA) issued the following statement regarding the ...t of the new annual wellness for Medicare benefici...le Care Act" that was introduced last night: ...vember 21, 2009 -- Eric J. Hall, president and chi...
    (Date:11/20/2009)...TON, Nov. 20 The Ameri...modify health care reform legislation released thi...alth insurance individual coverage mandate. The ac...date will minimize adverse selection stemming from...d by the bill. ,, "The individual mandate langu...
    (Date:11/20/2009)...Nov. 20 The American De...nd Drug Administration (FDA) to establish appropri... ,, Citing concern about the safety of whiteni...e benefit of professional consultation or examinat...plication of chemically based tooth whitening or b...
    (Date:11/20/2009)...YORK, Nov. 20 SIRIUS XM ...ill broadcast Doctor Radio Reports: What Every ... special hosted by veteran journalist Perri Peltz....h/20080819/NYTU044LOGO ) ,, Doctor Radio Rep...ams will air November 21 live at 10:00 am ET on...
    (Date:11/20/2009)... Based out of Dallas, TX, the new addition to...ucts that are made in the USA. , ...ue sky scrubs is an independent medical scrubs bra... production and distribution of hospital uniforms ...heir products via their online boutique, the Austi...
    Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2
    ...OLUMBUS, Ohio, Oct. 7 The Ohio Nurses,Association... today its,final round of endorsed candidates for ...nate:, SD 26 Karen Gillmor (R) Tiffin, Ohio Hous...e ONA-endorsed candidates for the Ohio General Ass...
    ...ASHINGTON, Oct. 7 Kristi Yamaguchi, Olympic,Gold ...e Stars, has been,named chairperson for the 2008 A...in an effort to help raise funds in support of the...onquer Tuberculosis. Today, the Lung Association i...
    ...ompression ultrasound similar to more expensive wh..., TUESDAY, Oct. 7 (HealthDay News) -- An older, si...alled deep vein thrombosis, or DVT -- is as effect...ession or duplex ultrasound -- was as good at dete...
    ... JACKSONVILLE, Fla. Based on results of a landma...pus see a future in which virtual biopsies will el...ot cancerous or will not morph into the disease. ... this increases time, expense and the potential fo...
    ...ifelink introduces Color Me Healthy(TM)/Salud Prim...ition curriculum, BENSENVILLE, Ill., Oct. 7 Life...sive campaign to bring a comprehensive diet and,nu...iabetes in minority children. Lifelink also will o...
    ...vailable Now! Everything a Man Wanted to Know But ...e 4.3 million babies born,in the U.S. each year bu...,now. BEING DAD is a revealing, entertaining and i...rocess. It includes,a wealth of advice from severa...
    Other Medicine News:Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3Health News:Mayo Clinic estimates new, tiny, super-sensitive probe could cut colon polyp removal in half 2Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 2Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 3Health News:BEING DAD DVD Offers a Sneak Peek at Pregnancy From a Guy's Point of View 2
    H. Pylori Rapid Test Strip
    BioSign® H. pylori - Rapid H. pylori Antibody (IgM/IgG/IgA) Test
    Clearview H. pylori II
    TRINITY BIOTECH UNI-GOLD H. PYLORI TEST
    Medicine Products: